| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.014 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |